Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment

Completed

Phase N/A Results

Eligibility Criteria

Inclusion criteria:
- patients with atrial fibrillation foreseen for Pradaxa anticoagulation according to physician's decision for stroke prevention
- patients with mild or moderate renal impairment
- age >= 18 years at enrollment
Exclusion criteria:
- severe renal impairment (Creatinine Clearance < 30 ml/min)